MYLAN $31.40

+0.70

17/5/2013 04:17 PM | NASDAQ : MYL | Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing

Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN

12 Mo. Price Change : 48% - MYL has outperformed the S&P 500 by 22%

Ticker	Name	Weight	% Change
IHE	ISHARES DOW JONES US PHARMACEU	3.20%	+0.43%
IBB	ISHARES NASDAQ BIOTECHNOLOGY	2.52%	+0.99%
JKI	ISHARES MORNINGSTAR MID VALUE	0.99%	+1.20%
IYH	ISHARES DOW JONES US HEALTHCAR	0.60%	+0.51%
IWP	ISHARES RUSSELL MIDCAP GROWTH	0.46%	+1.04%
IXJ	ISHARES S&P GLOBAL HEALTHCARE	0.39%	+0.27%
MTUM	ISHARES MSCI USA MOMENTUM FACT	0.28%	-0.21%
IWR	ISHARES RUSSELL MIDCAP INDEX	0.23%	+1.08%
IVW	ISHARES S&P 500 GROWTH INDEX	0.16%	+0.86%
SIZE	ISHARES MSCI USA SIZE FACTOR	0.14%	+0.25%

People viewing MYL also viewed: XCHO, TBET, ELTP, MSLI, CKGT

Ticker	Name	Volume	% Change
ACEL	TAMIR BIOTECHNOLOGY	12.3K	+1.86%
BOMDF	ALLIED HEALTHCARE GROUP	18.8K	+1.27%
HRDND	DC BRANDS INTERNATIONAL INC. N	2.6M	+1.00%
TRAB	THERABIOGEN	970.8K	+1.00%
NRGXQ	NEUROLOGIX	100.0K	+0.82%

View All

Teva Still Too Cheap, But Still Too Uncertain

(TEVA,NVS,MYL,ACT )

Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.

View All

Free Managed Futures Book

Get the four benefits of managed futures as outlined in this booklet.
FREE Options Trading Manual

If you are new to the options market, this free booklet is designed for you!
Forbes Wolfe Nanotech Report Nanotech 101

Get this Rare, First-Person Account of the Nanotechnology Industry, Absolutely Free!

The Presidential Second-Term Curse	How The Mega-Caps Shape Up		Investopedia Forex Outlook For March 2013	How Companies Can Attract Top Female Employees
	The Secret Finances Of The Vatican Economy	Why The 4% Rule No Longer Works For Retirees	Do You Dare Sue Your Broker?